>
Industry
Pharmaceuticals
Topic
Bankruptcy
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Bankruptcy in Pharmaceuticals

... used to treat diabetes or obesity. Saxenda, made by the pharma company Novo Nordisk, is one of a handful of successes and the only drug ...
... Egalet Corporation, a fully integrated specialty pharmaceutical company, reported that its net loss ...
... The Acura RDX compact crossover SUV has set an annual sales record, surpassing its ...
... into an asset purchase agreement to acquire four marketed products from Iroko Pharmaceuticals, Inc. (Iroko). If consummated, the proposed transaction will enable Egalet to focus ...
... doctors and patients about safety risks and costs. Other new drugs include Vivus Inc.’s Qsymia and Belviq from Eisai Inc. These drugs have been associated ...
... the deal. Celcuity plans to list on the Nasdaq as "CELC." [ts_bullet_primary] Krystal Biotech , a Pittsburgh, Penn.-based therapy company focused on dermatological diseases, priced ...
... due to the failure of its hepatitis B drug candidate, where GlobeImmune Inc. (GBIM) goes from here is still up in air. The company does ...
... According to its CEO, Diadexus Inc. (DDXS) is planning to follow in the footsteps of two of its ...
... the Novato, Calif., drug company said in a statement Tuesday. Cambridge-based Sarepta Therapeutics Inc. is developing a rival drug to treat the deadly muscle disease ...
... oligonucleotide and immune-oncology-based ACCURINS®. BIND has announced ongoing collaborations with Pfizer Inc., AstraZeneca AB, F. Hoffmann-La Roche Ltd., Merck & Co., or Merck (known as ...
Subscribe now for full coverage on Bankruptcy in Pharmaceuticals
Start My Free Trial